1. Home
  2. VTRS vs CPT Comparison

VTRS vs CPT Comparison

Compare VTRS & CPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • CPT
  • Stock Information
  • Founded
  • VTRS 1961
  • CPT 1993
  • Country
  • VTRS United States
  • CPT United States
  • Employees
  • VTRS N/A
  • CPT N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • CPT Real Estate Investment Trusts
  • Sector
  • VTRS Health Care
  • CPT Real Estate
  • Exchange
  • VTRS Nasdaq
  • CPT Nasdaq
  • Market Cap
  • VTRS 12.2B
  • CPT 10.9B
  • IPO Year
  • VTRS N/A
  • CPT 1993
  • Fundamental
  • Price
  • VTRS $10.77
  • CPT $102.39
  • Analyst Decision
  • VTRS Hold
  • CPT Buy
  • Analyst Count
  • VTRS 6
  • CPT 19
  • Target Price
  • VTRS $11.17
  • CPT $121.14
  • AVG Volume (30 Days)
  • VTRS 9.1M
  • CPT 1.4M
  • Earning Date
  • VTRS 11-06-2025
  • CPT 11-06-2025
  • Dividend Yield
  • VTRS 4.36%
  • CPT 4.11%
  • EPS Growth
  • VTRS N/A
  • CPT N/A
  • EPS
  • VTRS N/A
  • CPT 2.47
  • Revenue
  • VTRS $14,124,400,000.00
  • CPT $1,578,428,000.00
  • Revenue This Year
  • VTRS N/A
  • CPT $2.74
  • Revenue Next Year
  • VTRS $1.61
  • CPT $2.57
  • P/E Ratio
  • VTRS N/A
  • CPT $41.32
  • Revenue Growth
  • VTRS N/A
  • CPT 1.41
  • 52 Week Low
  • VTRS $6.85
  • CPT $97.17
  • 52 Week High
  • VTRS $13.55
  • CPT $127.65
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 57.88
  • CPT 49.76
  • Support Level
  • VTRS $9.92
  • CPT $99.44
  • Resistance Level
  • VTRS $11.28
  • CPT $103.93
  • Average True Range (ATR)
  • VTRS 0.35
  • CPT 2.09
  • MACD
  • VTRS 0.04
  • CPT 0.35
  • Stochastic Oscillator
  • VTRS 62.87
  • CPT 78.70

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.

Share on Social Networks: